Institute of Molecular Biotechnology

Institute of Molecular Biotechnology

The Institute of Molecular Biotechnology is an independent biomedical research organisation founded by the Austrian Academy of Sciences in cooperation with the pharmaceutical company Boehringer Ingelheim. The institute employs around 250 people from over 40 countries, who perform basic research. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Institute of Molecular Biotechnology, Austria, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

74%


Total
Publications

2.4K


Total Open
Publications

1.8K


Total
Citations

168K


Open Access
Percentage

74%


Total
Publications

2.4K


Total Open
Publications

1.8K


Total
Citations

168K

Wikipedia

Website

download

Breakdown

14% 44% 16% 26%

Publisher Open

14%

Both

44%

Other Platform Open

16%

Closed

26%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

020406080100120140160180200220Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

33%OA Journal

OA Journal 33%

455

Hybrid 48%

674

No Guarantees 19%

261

Other Platform Open

Domain 75%

1.1K

Institution 22%

318

Preprint 22%

315

Other Internet 16%

222

Public 8%

111

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
1.1K
Europe PMC
Domain
500
bioRxiv
Preprint
297
DOI
Other Internet
163
Semantic Scholar
Public
84
Le Centre pour la Communication Scientifique Directe - HAL - TYPE ART
Other Internet
35
Le Centre pour la Communication Scientifique Directe - HAL - Diderot
Institution
32
University of Cambridge - Apollo
Institution
31
Figshare
Public
31
University College London - UCL Discovery
Institution
27
1 / 20

Data updated 7 April 2025

Share

Share

Share